News Archives - IIS Biodonostia

Over 60% of Hearing Deficits in Newborns Are of Genetic Origin

Recently, was presented an international study for the early diagnosis of hipoacusias by means of genomic tools (GHELP project), led by the University of Navarra Clinic, in which 8 other centres from Spain, Portugal and France participate, including the IIS Biodonostia. Five out of every thousand children are born with some type of hearing ... + info

Biodonostia researcher Jesús Bañales co-heads a European Horizon 2020 project addressing 3 types of liver cancer

The research project is part of the European Research and Innovation Programme Horizon 2020, one of the most competitive and prestigious at international level, and is funded with €3.5 million. An international consortium co-headed by Dr Jesús Bañales, Head of the Hepatic Diseases Group at Osakidetza’s Biodonostia Health Research ... + info

First steps of the Multidisciplinary Unit to develop Bio-Models, Bio-Inks and 3D Bio-Printing at Biodonostia

Development of the 3D printing area is currently one of the main strategic R&D&I endeavours at the Biodonostia HRI. In line with the situation at other health research institutes and hospitals, the Biodonostia HRI has decided to promote a Multidisciplinary Unit on Bio-models, Bio-inks and 3D Bioprinting. This Unit will encompass the ... + info

Biodonostia, world leaders with a project on head and neck cancer

A report published in the Diario Vasco newspaper towards the end of the year refers to the current situation of a research project carried out at Biodonostia on head and neck cancer by Charles Lawrie, an Ikerbasque researcher and head of the Institute’s Oncology area, together with Lorea Manterola, a member of the centre’s Molecular […]

National and international experts analyse in San Sebastian the relationship between child health and environmental pollutants

The XV INMA Scientific Conference, organised by the University of the Basque Country (UPV/EHU), Biodonostia, the Basque Government and CiberEsp, took place on 14 and 15 November. At the conference, opened by Nekane Balluerka, rector of the UPV/EHU, Jon Etxeberria, Provincial Health Deputy for Gipuzkoa and Jesús Ibarluzea, principal researcher ... + info

Biodonostia researchers awarded prizes at the United European Gastroenterology Congress

The “UEG Week 2018” Congress organised by United European Gastroenterology, UEG, ran in Vienna from October 20 to 24. At the congress, attended by more than 12,000 participants from all over the world, with top level speakers, discussions focussed on current research topics, presenting the latest in gastroenterology and hepatology, looking ... + info

Biodonostia obtains the Stamp of Excellence in Human Resources Policies for Researchers awarded by the European Commission

The stamp accredits the Osakidetza Health Research Institute as a centre which manages its human resources policy in exemplary fashion, being a stimulating and favourable workplace The ‘Human Resources Strategy for Researchers’ (HRS4R) distinction awarded by the European Commission, publicly recognises research centres which develop Human ... + info

Biodonostia to co-lead an international project for studying the role of obesity in developing non-alcoholic fatty liver disease

Over the next 3 years, the Osakidetza Biodonostia Health Research Institute will co-lead a collaborative research project headed by the Faculty of Pharmacy, University of Lisbon, focussed on research into the part played by extracellular vesicles as non-invasive biomarkers of non-alcoholic fatty liver disease (or NAFLD), and on its development ... + info

The 4D-Healing project takes off at Biodonostia

On June 21st and 22nd, the Biodonostia HRI hosted the meeting to launch the European project “Data-Driven Drug Discovery for Wound Healing (4D-HEALING)”, coordinated by Dr. Marcos J. Araúzo-Bravo, leader of the Institute’s Computational Biology and Systems Biomedicine Group, in which Dr. Ander Izeta from the Tissue Engineering Group ... + info

Biodonostia contributes with its research to improving the identification and treatment of ALS

ALS is an enormously heterogeneous disease in regard to the progression rate of its symptoms and survival time, and there are no tools to predict these clinical variables. However, an early prognosis on development of the disease could enable neurologists to anticipate decisions which favour the patient’s quality of life and to more ... + info

BioNet Access